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Acceptance of an ofﬁcial classiﬁcation for the family Papillomaviridae based purely on DNA sequence
relatedness, was achieved as late as 2003. The rate of isolation and characterization of new papilloma-
virus types has greatly depended on and subjected to the development of new laboratory techniques.
Introduction of every new technique led to a temporarily burst in the number of new isolates. In the
following, the bumpy road towards achieving a classiﬁcation system combined with the controversies of
implementing and accepting new techniques will be summarized. An update of the classiﬁcation of the
170 human papillomavirus (HPV) types presently known is presented. Arguments towards the
implementation of metagenomic sequencing for this rapidly growing family will be presented.
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viruses could be isolated from lesions or body ﬂuids by exposing
the samples to in vitro propagation followed by puriﬁcation and
characterization of virus particles. Taxonomic criteria used by the
International Committee on Taxonomy of Viruses (ICTV) for
species demarcation were based on genome sequence relatedness,
natural host range, cell and tissue tropism, pathogenicity and
cytopathology, mode of transmission, as well as physiochemical
and antigenic properties (van Regenmortel et al., 1997). Papillo-
maviruses have posed an exception to the classical rules applied
for establishing a classiﬁcation system right from the initial
reports when two groups began isolating papillomaviruses from
human tissues (Gissmann et al., 1977; Gissmann and zur Hausen,
1976; Favre et al., 1975; Orth et al., 1978) and when the diversity of
human papillomaviruses became evident. An adequate tissue
culture system to propagate these viruses on a large scale was
not available. Similarly, these viruses could not be transmitted to
laboratory animals. The availability and development of new
laboratory techniques at that time through to today, have dictatedll rights reserved.not only the rate with which new papillomaviruses were identi-
ﬁed, but have also inﬂuenced the level of success in isolating and
characterizing full-length genomes of members of the family
Papillomaviridae. In parallel, continuous discussions at Interna-
tional Papillomavirus meetings amongst researchers in the ﬁeld on
deﬁning and accepting new papillomavirus types have stimulated
reconsideration of deﬁnitions and conditions. The ICTV was
approached for recognition of an ofﬁcial classiﬁcation system for
the papillomaviruses as early as the 1980s. It was however only in
2003 when the present classiﬁcation based on sequence simila-
rities (de Villiers et al., 2004) was ﬁnally accepted. This review will
describe the milestones, as well as the many cross-roads, which
had to be dealt with. The most recent cross-road brought along by
the application of modern techniques (metagenomics) applied for
identifying and isolating new viruses will be discussed.
The existence of multiple human papillomavirus types was
initially recognized by digestion of double stranded DNA genomes
using a very limited number of available restriction enzymes. DNA
was puriﬁed from papillomavirus particles obtained from warts.
Physical maps of the generated genome fragment lengths were
compiled (Gissmann et al., 1977; Gissmann and zur Hausen, 1976;
Favre et al., 1975; Orth et al., 1978). Other laboratories soon
followed leading to each laboratory having its own nomenclature
Fig. 1. Excerpt of a report on the ﬁrst workshop on papillomaviruses held in Alabama in 1979.
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papillomaviruses (Coggin and zur Hausen, 1979) to unify the
nomenclature—human papillomavirus HPV followed by a num-
ber—providing priority to publication date, thereby regarding the
ﬁrst isolation as the prototype. Sequence variations reﬂected in
restriction fragment patterns deﬁned subtypes (Fig. 1). Further-
more, a new HPV type would be deﬁned as a 7.9-kilobase closed
circular, double-stranded DNA molecule which showed less than
50% similarity to any known HPV type. This similarity was to be
determined by using liquid hybridization under stringent condi-
tions. The development of the cloning methodology resulted in the
complete genome of HPV1 being cloned in 1980 (Danos et al.,
1980; Heilmann et al., 1980), followed by applying the ﬁrst DNA
sequencing methods available to generate the HPV1 DNA sequence
(Danos et al., 1982).
A genome organization for HPV was established by initial
colinear DNA comparisons to, and subsequent DNA sequencing
of the bovine papillomavirus type 1 (BPV1) (Chen et al., 1982). All
HPV types contained at least six early genes (E1–E7) and two late
genes (L1, L2) as well as an upstream regulatory region.
Reports of isolation of papillomaviruses HPV16 and HPV18 and
their possible association with cervical cancer (Dürst et al., 1983;
Boshart et al., 1984) stimulated papillomavirus research on an
international level. Rapid increase in the isolation and character-
ization of new HPV types called for the decision made at the
annual Papillomavirus Workshop held in Kuopio (1985), to estab-
lish Reference Centers where the numerous HPV types would be
deposited to enable comparisons between new isolates and the
already existing HPV types prior to allocating a subsequent HPVnumber. Reference Centers in France, the United States and
Germany were initially planned, but only the Reference Center in
Heidelberg, Germany came to bearing. All HPV isolates have since
then been collected here and kept as reference stocks. Agreement
amongst scientists in the ﬁeld was that information (relatedness,
origin) on submitted clones would be kept conﬁdential until the
scientist involved would publish the information. By 1989, 60 new
HPV types, as well as a number of duplicates of known types, had
been isolated and characterized (reviewed in de Villiers (1989)).
HPV types were commonly grouped as either cutaneous or
mucosal, depending on the type of tissue of origin. Available
technologies greatly inﬂuenced the spectrum of HPV types iso-
lated. Labeled HPV DNA was used as probe for non-stringent
hybridization against cellular DNA to identify putative new HPV
types. Phage libraries of restricted cellular DNA were screened
accordingly. Other factors determining spectrum, sensitivity and
speciﬁcity of detection included viral copy numbers present in a
lesion and the degree of relatedness between HPV types. A small
fragment of the HPV14 prototype was never cloned, because it had
been missed in the original cloning (Kremsdorf et al., 1984) and no
other HPV14 isolate was ever submitted to the Reference Center. In
addition, the increasing spectrum of HPV types and clinical lesions
harboring papillomavirus DNA, stressed the huge deﬁcit in under-
standing cell and tissue tropism, pathogenicity, cytopathology and
antigenic properties of these virus infections. This delayed larger
studies aimed at collecting epidemiological data. Sequencing of
complete genomes of HPV types was very slow and tedious and
results very often included several sequencing errors which were
corrected by later re-sequencing of HPV prototypes. HPV prototype
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early 90s (Delius and Hofmann, 1994). Interestingly, the sequences
of HPV isolates harboring interrupted E1 ORFs were conﬁrmed. Its
biological meaning remains to be deﬁned. It is clear that the
prototypes in the Reference Center do not necessarily represent
the most prevalent variant of a speciﬁc HPV type in a clinical
context. To deﬁne the latter, large studies are required concentrat-
ing in isolating the respective HPV types and collecting the
respective clinical and pathological data. This will probably never
be achieved as present information for the vast majority of HPV
types does not extend beyond the report of their isolation.
Availability of the polymerase chain reaction and self-assembly
of viral capsid proteins in vitro (Salunke et al., 1986) initiated the
next phase in papillomavirus research. The conserved L1 gene
played the major role in designing primers for use in PCR reactions
(Manos et al., 1989), as well as in synthesizing virus-like particles.
Earlier in vitro data (reviewed in zur Hausen (1989, 2009)) could
now be conﬁrmed by larger epidemiological studies screening
genital lesions revealing high relative risks for HPV 16 and HPV 18
infections in the pathogenesis of anogenital cancers (Munoz et al.,
1992; Schiffman et al., 1993). PCR using L1 consensus primers led
to the identiﬁcation of a large number of putative new HPV types.
Gradually reports appeared describing the use of PCR primers
covering the E6 and E7 genes. This made it difﬁcult to identify
whether amplicons from different regions of the genome belonged
to the same putative HPV type. The selection of primers, whether
degenerate or consensus primers, deﬁnitely distorted the true
pattern of prevalence and lesion association, mainly because of the
varying sensitivity and speciﬁcity with which respective primer
combinations would amplify speciﬁc papillomavirus types. It was
virtually impossible to develop primers amplifying all knownTable 1
Update on names, accession numbers, references, names of partial fragments, as well a
HPV
Type: Accession number Reference
HPV 70 U21941 Forslund and Hansson (1996)
HPV 71 AB040456 Matsukura and Sugase (2001)
HPV 74 AF436130 Terai and Burk (2002)
HPV 75 Y15173 Delius et al., 1998)
HPV 76 Y15174 Delius et al. (1998)
HPV 77 Y15175 Delius et al. (1998)
HPV 78 AB793779 Sata et al. (unpublished)
HPV 79 replaced by HPV 91 (AF070938) Terai and Burk (2002)
HPV 81 AJ620209 Matsukura and Sugase (2001)
HPV 83 AF151983 Brown et al. (1999)
HPV 84 AF293960 Terai and Burk (2001)
HPV 85 AF131950 Chow and Leong (1999)
HPV 89 AF436128 Terai and Burk (2002)
HPV 90 AY057438 Terai and Burk (2002)
HPV 91 AF419318 Terai and Burk (2002)
HPV 92 AF531420 Forslund et al (2003)
HPV 93 AY382778 Vasiljevic et al. (2007)
HPV 94 AJ620211 de Villiers and Gunst (2009)
HPV 95 AJ620210 Egawa et al. (2005)
HPV 96 AY382779 Vasiljevic et al. (2007)
HPV 98 FM955837 de Villiers and Gunst (2009)
HPV 99 FM955838 de Villiers and Gunst (2009)
HPV 100 FM955839 de Villiers and Gunst ( (2009)
HPV 104 FM955840 de Villiers and Gunst (2009)
HPV 105 FM955841 de Villiers and Gunst (2009)
HPV 107 EF422221 Vasiljevic et al. (2008)
HPV 109 EU541441 Ekström et al. (2010)
HPV 110 EU410348 Vasiljevic et al. (2008)
HPV 111 EU410349 Vasiljevic et al. (2008)
HPV 112 EU541442 Ekström et al. (2010)
HPV 113 FM955842 de Villiers and Gunst (2009)
HPV 114 GQ244463 Ekström et al. (2010)
HPV 115 FJ947080 Chouhy et al. (2010)papillomaviruses with equal sensitivity and speciﬁcity. Grave
reservations on accepting full-length genomes generated by PCR
ampliﬁcation were however expressed by both the community
and ICTV members. It was feared that over-ampliﬁcation could
lead to inclusion of artifacts and the ICTV did not accept artiﬁcially
created viruses (reviewed in de Villiers (2001)). Ongoing analyses
of amplicons obtained from samples of healthy skin of both
humans and animals revealed an enormous diversity of yet
unknown papillomaviruses (Antonsson et al., 2000, 2003;
Antonsson and Hansson, 2002), stressing the necessity to accept
new techniques to generate full-length genomes.
At the same time intensive debating was ongoing among the
papillomavirologist community whether data from partial PCR
amplicons should be recognized as new HPV types or whether the
existing rule of submission of the complete genome to the Reference
Center should be upheld. The importance of availability of full-length
genomes was reiterated, although it was decided to modify the
deﬁnition of a new papillomavirus type to the DNA sequences of the
L1, E6 and E7 ORFs each having less than 90% similarity to the closest
related known papillomavirus type. The decision to include the E6
and E7 genes was motivated by their involvement in immortalization
and was a reﬂection of the dominating interest in HPV types involved
in mucosal lesions. It soon became evident that this deﬁnition could
not hold and was again modiﬁed in 1995 at the Papillomavirus
Workshop held in Quebec, to include the sequence of only L1 ORF
being less than 90% similar to the closest known HPV type. The
reasonwas the recognition of E7 ORF of the newly characterized HPV
77 having 97% DNA identity to E7 of HPV 29, whereas E6 and L1 ORFs
shared less than 90% to the corresponding ORFs of HPV 29 (Delius
et al., 1998). Table 1 lists HPV types (starting with HPV70) initially
identiﬁed as partial PCR fragments.s newly isolated HPVs.
Other name (partial PCR fragment or full-length isolate)
CP141-7
CP8061
AE10
vs40-1
CR148-59
vs93-1
FAIMVS3, XS2
JC9813-A
CP8304
LVX82, MM7
MM8, PAP155
HLT7474
CP6108, AE6, X06/X08
AE11, Han831, Han353, JC9710
AE13, JC9813
FAIMVS2
FAIMVS6
DL40
FA47
GA1-3
GA3-1
DL267, vs73-1, FA53
DL253, FA75
DL294
FA85, DL285
FA137
FA5
FA51
FA164
DL250
SW1
A3, GC02
Table 1 (continued )
HPV Other name (partial PCR fragment or full-length isolate)
Type: Accession number Reference
HPV 116 FJ804072 Li et al. (2009)
HPV 117 GQ246950 Köhler et al. (2010)
HPV 118 GQ246951 Köhler et al. (2011)
HPV 119 GQ845441 Bottalico et al. (2012) FA155
HPV 120 GQ845442 Bottalico et al. (2012) SIBX-3a, FA16
HPV 121 GQ845443 Bottalico et al. (2012)
HPV 122 GQ845444 Bottalico et al. (2012 vs92-1
HPV 123 GQ845445 Bottalico et al. (2012) FA136
HPV 124 GQ845446 Bottalico et al. (2012) FA23
HPV 125 FN547152 Kovanda et al. (2011b) SIBX9
HPV 126 AB646346 Egawa et al. (2012)
HPV 127 HM011570 Schowalter et al. (2010) R3a
HPV 128 GU225708 Köhler et al. (2011)
HPV 129 GU233853 Köhler et al. (2011)
HPV 130 GU117630 Köhler et al. (2011) FA147
HPV 131 GU117631 Köhler et al. (2011)
HPV 132 GU117632 Köhler et al. (2011) FA78
HPV 133 GU117633 Köhler et al. (2011) FA44
HPV 134 GU117634 Köhler et al. (2011) FA1.2
HPV 135 HM999987 Bottalico et al. (2012) FA28, NJ3500
HPV 136 HM999988 Bottalico et al. (2012 FA8, CL3865
HPV 137 HM999989 Bottalico et al. (2012) NJ2801H
HPV 138 HM999990 Chen et al. (1982) FA20, GH13
HPV 139 HM999991 Chen et al. (1982) GH1646
HPV 140 HM999992 Bottalico et al. (2012) NJ2801C1
HPV 141 HM999993 Bottalico et al. (2012) FA73, NJ2801Cn
HPV 142 HM999994 Chen et al. (1982) FA67, GH1302
HPV 143 HM999995 Bottalico et al. (2012) FAIVSM10, CL3220
HPV 144 HM999996 Bottalico et al. (2012) FA83, CL3740
HPV 145 HM999997 Bottalico et al. (2012) IA16, CL4112
HPV 146 HM999998 Chen et al. (1982) FA35, GH1677
HPV 147 HM999999 Chen et al. (1982) FA13, GH659
HPV 148 GU129016 Köhler et al. (2011)
HPV 149 GU117629 Köhler et al. (2011)
HPV 150 FN677755 Kovanda et al. ( (2011a) SIBX1, FA22
HPV 151 FN677756 Kovanda et al. (2011a) SIBX2
HPV 152 Chen and Burk (personal communication) FA18
HPV 153 JN171845 Sturegard et al. (2013)
HPV 154 Ore and Forslund, (personal communication) FAD13
HPV 155 JF906559 Ekström et al. (2011) SE42
HPV 156 JX429973 Chouhy et al. (2013) GC01
HPV 157 Chouhy et al. (2010) GC08
HPV 158 Chouhy et al. (2010) GC23
HPV 159 HE963025 Kocjan et al. (in preparation) SIBX8
HPV 160 Kiyono (personal communication)
HPV 161 JX413109 Li et al. (2012) KC1
HPV 162 JX413108 Li et al. (2012) KC2
HPV 163 JX413107 Li et al. (2012) KC3
HPV 164 JX413106 Li et al. (2012) KC4
HPV 165 JX444072 Li et al. (2012) KC7
HPV 166 JX413104 Li et al. (2012) KC9
HPV 167 Li et al. (2012) KC10
HPV 168 Li et al. (2012) KC15, SE64
HPV 169 JX413105 Li et al. (2012) KC6, vs202-8
HPV 170 JX413110 Li et al. (2012) KC8
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remained evident. Biological and pathological, as well as some
functional information for the more prevalent HPV types was
continuously extended, whereas rare HPV types did not receive
any subsequent attention (reviewed in de Villiers (1989, 1994,
1997, 1998, 2001) and de Villiers et al. (2004)). The only consistent
information available for all papillomavirus types was sequence
data. This was utilized to deﬁne relationships between papilloma-
virus types. The conserved region in L1 ORF (Chan et al., 1992) and
the E6 ORF (van Ranst et al., 1992) was used to obtain phylogenetic
information. Subsequent studies demonstrated that the use of the
conserved region of the L1 gene was sufﬁcient, especially in view
of no evidence of recombination between papillomavirus types
(Bernard et al., 1994). A stretch of highly conserved amino acidresidues was contained in a 291 bp segment of the L1 ORF
(spanned by the MY09 and MY11 primers). This was used to
construct phylogenetic trees resulting in taxonomic supergroups A
to E. Different taxonomic levels were recognized splitting each
supergroup into groups. Supergroup A (genital HPVs) contained 11
groups and supergroup B (EV HPV types) 2 groups. HPV 1, HPV63
and HPV41 sorted in supergroup E together with a few animal
papillomaviruses (Chan et al., 1995). The commonly used grouping
of mucosal versus cutaneous HPV types was not upheld in the
phylogeny, conﬁrming earlier reported analyses of clinical lesions
(reviewed in de Villiers (1994) and de Villiers et al. (2004)).
Although these phylogenetic groupings or clusters presented in
our application were not accepted by the ICTV in 2001, this analysis
(Chan et al., 1995) formed the base for the present classiﬁcation of
E.-M. de Villiers / Virology 445 (2013) 2–106papillomaviruses. Fortunately Claude Fauquet (then member of the
ICTV) initiated steps to include sequence information in the
taxonomic guidelines speciﬁed by the ICTV (Fauquet et al., 2003).
Being actively involved in the family Geminiviridae, the family
Papillomaviridae interested him and he approached us with a
phylogenetic analysis of all complete genomes of papillomaviruses
available at the time in the databanks. This analysis proved to be
almost identical to phylogeny generated from the complete L1
sequence, which helped to convince him that we could continue
using L1 as criterium for our classiﬁcation. His pairwise nucleotide
sequence comparisons (de Villiers et al., 2004) underlined our
previous deﬁnition of a new papillomavirus type. An important
aspect from our side was to maintain continuity of established
criteria regularly used in papillomavirus research. Rules of the
International Code of Virus Classiﬁcation and Nomenclature include
“aiming for stability” (rule 2.1(I)) and “existing names should be
retained wherever possible” (rule 3.9) (http://www.ictvonline.org).
The groupings mentioned above (Chan et al., 1995) had very rapidly
been accepted by scientists leading to e.g. “HPV16 belonging to A9”Fig. 2. Phylogenetic analysis based on the L1 ORF sequences of 170 HPV types, as well a
was constructed using the MEGA5.1 program.being common use in publications. Here rule 3.25 stated that “newly
designated combinations of letters and numerals alone are not
legal”. We therefore proposed to use the Greek alphabet which had
already been accepted by the ICTV in a different context for other
virus families. These considerations (sequence of full-length L1 ORF,
Greek alphabet) were included in our proposal submitted in 2003.
Claude Fauquet was crucial in preparing the proposal (including 96
HPV types and 22 animal viruses), as well as inﬂuencing the ﬁnal
decision by the ICTV in 2003 inwhich the classiﬁcation of the family
Papillomaviridae was accepted as it stands today (de Villiers et al.,
2004). A counter-argument of the limited number of letters in the
Greek alphabet was later circumvented (Bernard et al., 2010). The
exact criteria for classiﬁcation, as well as proposed future amend-
ments, are extensively reviewed in de Villiers et al. (2004) and
Bernard et al. (2010).
Isolating and characterizing new HPV types had been ongoing.
Presently 170 HPV types have been accepted. Long-PCR ampliﬁca-
tion with speciﬁc primers designed on initially isolated partial PCR
fragments was tedious. The introduction of multiple primed rollings single animal papillomaviruses, using the maximum likelihood method. The tree
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cles (Rector et al., 2004) and resulted in a sudden burst in numbers
of newly isolated and characterized HPV types. Initial RCA ampliﬁ-
cation with subsequent PCR ampliﬁcation using speciﬁc primers
was helpful in cases of samples with extremely low HPV copy
numbers (de Villiers and Gunst, 2009). Reports on a relative high
prevalence of unknown HPV types on the surface of the skin
(Antonsson et al., 2000, 2003; Antonsson and Hansson, 2002) and
reports on smaller studies investigating the role of papillomaviruses
in the pathogenesis of non-melanoma skin cancer, led to a general
shift in interest in papillomavirus research. This and the use of RCA
led to an increase in HPV types in the genus Betapapillomavirus
from 25 (2004) to 45 (2013) and in genus Gammapapillomavirus
from 7 (2004) to 54 in 2013. In contrast, HPV types in genus
Alphapapillomavirus increased from 59 to 66 during this time
period. An updated phylogenetic analysis including all 170 HPV
types, as well as single animal papillomaviruses, is presented in
Fig. 2. HPV161, HPV162 and HPV166 together represent a new
species and HPV156 and HPV 167 each a separate new species. No
additional species for genera Alpha- or Betapapillomavirus were
recognized.
Gathering of clinical and biological information for many of the
HPV types in genus Alphapapillomavirus was supported and
stimulated by molecular biological data—and later epidemiologi-
cal—demonstrating the importance of individual HPV types in the
pathogenesis of genital cancer. Presently molecular data on HPV
types associated with non-melanoma skin cancer are scarce and
epidemiological data are not convincing for a role at all. Molecular
studies have highlighted the diversity of the HPV types in the
genera Beta- and Gamma-papillomavirus—single HPV types each
follow individual pathways or interactions in the cell (de Villiers
et al., 1999; Fei and De Villiers, 2012; Massimi et al., 2008;
Underbrink et al., 2008). The tremendous and rapid expansion of
isolated HPV types of the Beta- and Gammapillomavirus pinpoints
the urgent need for molecular and biological data of these HPV
types if continuous future isolation is to be meaningful.
The genome organization of HPV101, HPV 103 and HPV 108 (γ6)
differs from all other HPV types in that they do not have an E6
gene (similar to a number of animal papillomaviruses). HPV108 E7
induces dysplastic modiﬁcations in organotypic raft cultures
(Nobre et al., 2009). It is not difﬁcult to envision the existence of
other, similarly different, but yet unidentiﬁed HPV types. In
addition, presently unknown HPV types may exist which have
even other genome organizations. HPV1 and HPV63 (genus mu-
papillomavirus), as well as HPV41 (genus nu-papillomavirus),
remain the only representatives of these respective genera harbor-
ing HPV types. It is extremely unlikely, based on our present
knowledge of HPV types, that these genera contain only 1 or 2Table 2
Human papillomaviruses identiﬁed by metagenomic sequencing and available in the dat
type, as well as partial fragment originally described.
Name (m¼metagenomics) Accession number Reference
mFA69 KC108722 Johansson et al. (
mSE87 KC108721 Johansson et al. (
mﬁ864 KC311731 Phan et al. (2013
mSD2 SRA051429 Mokili et al. (201
mKN1 JF966371 Foulongne et al. (
mKN2 JF966372 Foulongne et al. (
mFS1 JF966373 Foulongne et al. (
mKN3 JF966374 Foulongne et al. (
mFD1 JF966375 Foulongne et al. (
mFD2 JF966376 Foulongne et al. (
mCG1 JF966377 Foulongne et al. (
mCG2 JF966378 Foulongne et al. (
mCG3 JF966379 Foulongne et al. (papillomavirus types. Identiﬁcation of additional very distantly
related papillomaviruses calls for more diverse methods of identi-
ﬁcation and isolation.
A vast spectrum and number of viruses are being identiﬁed by
high throughput sequencing of biological samples (metagenomic
sequencing and analysis). It allows for unbiased detection of known
and unknown viruses (and other organisms). Heavy debate on
different levels is again continuing whether viruses identiﬁed by this
method should be accepted or not. The genomes of HPV116 (γ9) (Li
et al., 2009) and HPV155 (γ7) (Ekström et al., 2011; Bzhalava et al.,
submitted for publication) were originally identiﬁed by metage-
nomics. These HPV types were subsequently re-ampliﬁed from the
respective samples, cloned and submitted to the Reference Center.
The genomes of 13 putative HPVs have been identiﬁed by metage-
nomic sequencing during the past year (Mokili et al., 2013; Foulongne
et al., 2012; Johansson et al., 2013; Phan et al., 2013). These putative
HPV genomes are listed in Table 2 and the afﬁxm indicates the mode
(metagenomics) of their identiﬁcation. In one case mCG1 was
identiﬁed at the level of 98% identity to the prototype HPV146
(Foulongne et al., 2012), and in another the full-length genome
mFA69 (Johansson et al., 2013) of a partial PCR fragment FA69
(Antonsson et al., 2003) was generated. mKN1 is the full-length
genome of partial PCR fragment vs19-6 (Shamanin et al., 1996), mCG1
that of FA35 (Antonsson et al., 2003) and mCG2 of FA106 (Olsson
et al., unpublished). All these papillomaviruses form part of genus
Gammapapillomavirus (Fig. 3) and 4 of them represent 3 new species.
HPV156 represents a new species together with mFi864 (Phan et al.,
2013), whereas mFD1 and mKN1 (Foulongne et al., 2012) together
represent another new species. HPV60 has to date been the only
representative of species γ4, but is now joined by mFS1 (Foulongne
et al., 2012) and mSE87 (Johansson et al., 2013). It is evident many of
these newly identiﬁed HPV types are not clustering with known HPV
types, therefore indicating that identifying new HPV types by using
metagenomic sequencing will most probably open to date unreach-
able corridors for papillomavirus research. Ways to obtain these
putative HPV types in the Reference Center in order to make it
available for the community needs to be discussed.
Accepting putative new HPV types only after submission of the
cloned full-length genome to the Reference Center has its merits
and has proved to be very successful over 28 years. The main
advantage is the availability of such a clone to the community and
the necessity to verify a submitted clone has in some instances
been evident. The situation for animal papillomaviruses is very
different. Lack of collaboration during the same time period has
made access to newly isolated/cloned animal papillomaviruses
almost impossible. Attempts to establish a Reference Center for
animal papillomavirus has thus far been without success, leading
to the present acceptance of new animal papillomaviruses basedabanks. Accession numbers, references and closest related identiﬁed or known HPV
Closest related HPV type Other name/PCR fragment
2013) HPV121 82% FA69
2013) mFS1 79% HPV60 68%
) HPV156 69%
3) HPV135 74%
2012) mFD1 74% HPV65 69% vs19-6
2012) HPV161 65%
2012) mSE87 79% HPV60 69%
2012) HPV141 70%
2012) mKN1 74% HPV142 68%
2012) HPV129 71%
2012) HPV146 98% FA35
2012) HPV148 78% FA106
2012) mCG2 72% HPV148 71%
Fig. 3. Phylogenetic tree based on the L1 ORF sequences of 170 HPV types, single animal papillomaviruses and newly identiﬁed human papillomaviruses using metagenomic
sequencing. The maximum likelihood method was used for the analysis and the tree was constructed using the MEGA5.1 program.
E.-M. de Villiers / Virology 445 (2013) 2–108solely on sequence data. The difference in conditions for accep-
tance by the community between human versus animal papillo-
maviruses is not acceptable and should be reconsidered. If it is not
modiﬁed, the reluctance to accept and include human papilloma-
virus types generated by metagenomics is greatly unjustiﬁed.
A (long awaited) statement on the ICTV website: “The advent of
nucleotide sequence determination has revolutionized biology and
largely rationalized taxonomy, including that of viruses” (http://
www.ictvonline.org/virusTaxonomy) demonstrates that change
can be accepted and should be helpful in overcoming yet another
hurdle in the history of the family Papillomaviridae on the road to
updating the classiﬁcation.Acknowledgments
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